Aurobindo Pharma Limited — JV/Acquisition, 30-06-2026: Acquisition

Aurobindo Pharma's US subsidiary, APUSA, has completed its acquisition of Lannett Company, Inc., USA, following U.S. regulatory approval. Lannett is now a wholly owned subsidiary of APUSA, marking a significant strategic expansion. This move aims to enhance the availability of essential medicines by combining capabilities and resources, leveraging Lannett's operations. The integration strengthens APUSA's talent base and operational footprint, bringing over 400 new employees. This acquisition is poised to deliver sustained, long-term value by expanding essential medicine access for patients and customers.